InSilico Medicine Cayman TopCo (HKG:3696)
47.00
+2.10 (4.68%)
At close: Jan 9, 2026
HKG:3696 Revenue
InSilico Medicine Cayman TopCo had revenue of $27.46M USD in the half year ending June 30, 2025. This brings the company's revenue in the last twelve months to $53.60M. In the year 2024, InSilico Medicine Cayman TopCo had annual revenue of $85.83M with 67.71% growth.
Revenue (ttm)
$53.60M
Revenue Growth
+67.71%
P/S Ratio
62.08
Revenue / Employee
$168.03K
Employees
319
Market Cap
26.12B HKD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 85.83M | 34.65M | 67.71% |
| Dec 31, 2023 | 51.18M | 21.03M | 69.77% |
| Dec 31, 2022 | 30.15M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition